We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+15.41%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$6.93B
AUM Growth
+$1.24B
(+22%)
Cap. Flow
+$454M
Cap. Flow
% of AUM
6.54%
Top 10 Holdings %
Top 10 Hldgs %
16.4%
Holding
1,110
New
146
Increased
497
Reduced
266
Closed
160
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVR
NVR
|
+$34.9M |
| 2 |
SBA Communications
SBAC
|
+$31.5M |
| 3 |
Lennox International
LII
|
+$29.1M |
| 4 |
McKesson
MCK
|
+$24.8M |
| 5 |
Cable One
CABO
|
+$23.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$55.8M |
| 2 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$52.7M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$42.5M |
| 4 |
Intuitive Surgical
ISRG
|
+$35.5M |
| 5 |
XLNX
Xilinx Inc
XLNX
|
+$33.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.87% |
| 2 | Financials | 16.58% |
| 3 | Consumer Discretionary | 13.8% |
| 4 | Industrials | 12.36% |
| 5 | Healthcare | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Rapid7
RPD
$654M
| $8.24M | 0.12% |
162,780
+25,480
| +19% | +$1.09M |
|
227
Teradyne
TER
$51.6B
| $8.2M | 0.12% |
205,930
-20,690
| -9% | -$773K |
|
228
Howard Hughes
HHH
$3.95B
| $8.12M | 0.12% |
77,390
+25,637
| +50% | +$2.66M |
|
|
IPHI
229
DELISTED
INPHI CORPORATION
IPHI
| $8.11M | 0.12% |
185,405
+90,495
| +95% | +$3.6M |
|
|
REGI
230
DELISTED
Renewable Energy Group, Inc.
REGI
| $8.1M | 0.12% |
368,846
-4,020
| -1% | -$104K |
|
231
Moog Inc Class A
MOG.A
$13.1B
| $8.09M | 0.12% |
93,085
+20,020
| +27% | +$1.74M |
|
232
Cooper-Standard Automotive
CPS
$505M
| $7.97M | 0.12% |
169,653
+61,374
| +57% | +$3.95M |
|
|
CRAY
233
DELISTED
Cray, Inc.
CRAY
| $7.96M | 0.11% |
305,356
+121,215
| +66% | +$2.82M |
|
234
ONE Gas
OGS
$5.03B
| $7.92M | 0.11% |
88,964
-17,930
| -17% | -$1.51M |
|
235
Acuity Brands
AYI
$9.92B
| $7.88M | 0.11% |
65,620
+38,440
| +141% | +$4.78M |
|
236
SPS Commerce
SPSC
$2.42B
| $7.85M | 0.11% |
147,948
-10,274
| -6% | -$503K |
|
|
TGI
237
DELISTED
Triumph Group
TGI
| $7.83M | 0.11% |
411,035
+153,061
| +59% | +$2.88M |
|
238
First Hawaiian
FHB
$3.39B
| $7.83M | 0.11% |
300,645
-17,140
| -5% | -$443K |
|
239
Howmet Aerospace
HWM
$115B
| $7.79M | 0.11% |
531,709
-215,812
| -29% | -$3.09M |
|
240
Trane Technologies
TT
$106B
| $7.79M | 0.11% |
72,150
+7,670
| +12% | +$777K |
|
241
Capital One
COF
$126B
| $7.79M | 0.11% |
95,307
-66,330
| -41% | -$5.39M |
|
|
CTRA
242
DELISTED
Coterra Energy
CTRA
| $7.78M | 0.11% |
298,030
+235,460
| +376% | +$5.91M |
|
243
Advance Auto Parts
AAP
$3.49B
| $7.77M | 0.11% |
45,559
+39,629
| +668% | +$6.4M |
|
244
Stratasys
SSYS
$696M
| $7.75M | 0.11% |
325,349
+5,470
| +2% | +$132K |
|
|
AMTD
245
DELISTED
TD Ameritrade Holding Corp
AMTD
| $7.75M | 0.11% |
154,990
+69,500
| +81% | +$3.77M |
|
|
PRAH
246
DELISTED
PRA Health Sciences, Inc.
PRAH
| $7.71M | 0.11% |
+69,881
| New | +$7.3M |
|
247
NMI Holdings
NMIH
$3.28B
| $7.69M | 0.11% |
297,424
+120,069
| +68% | +$2.74M |
|
248
Medtronic
MDT
$108B
| $7.67M | 0.11% |
84,210
+58,350
| +226% | +$5.22M |
|
|
HZNP
249
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $7.65M | 0.11% |
289,539
-31,800
| -10% | -$754K |
|
|
AXE
250
DELISTED
Anixter International Inc
AXE
| $7.63M | 0.11% |
135,937
+52,470
| +63% | +$3.07M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q1 2019 Portfolio in Review
As of Q1 2019, Jacobs Levy Equity Management held 1,110 positions worth $6.93B, up 22% from $5.69B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Jacobs Levy Equity Management deployed $454M of net new capital in Q1 2019, opening 146 new positions and adding to 497 existing holdings. Its largest new stake was AbbVie: 282,010 shares worth $22.7M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Wellcare Health Plans, Inc., an estimated $52.7M trimmed.
- Jacobs Levy Equity Management's largest Q1 2019 buy was AbbVie: 282,010 shares worth $22.7M.
- Jacobs Levy Equity Management added most to NVR in Q1 2019, an estimated $34.9M increase.
- Jacobs Levy Equity Management's biggest Q1 2019 reduction was Wellcare Health Plans, Inc., cutting an estimated $52.7M.
- Jacobs Levy Equity Management fully exited Celgene Corp in Q1 2019, selling an estimated $55.8M.
- Jacobs Levy Equity Management's ten largest holdings make up 16% of its $6.93B portfolio in Q1 2019.
- Jacobs Levy Equity Management opened 146 new positions and closed 160 in Q1 2019.
- Jacobs Levy Equity Management's portfolio value rose 22% quarter-over-quarter to $6.93B.
Based on Jacobs Levy Equity Management's 13F filing for Q1 2019, filed 14 May 2019.